Notice: This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HCAQ vs. CHEK, GEHC, HOLX, BFLY, NNOX, LNSR, KPTI, RBOT, QNCX, and EDAPShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), LENSAR (LNSR), Karyopharm Therapeutics (KPTI), Vicarious Surgical (RBOT), Quince Therapeutics (QNCX), and Edap Tms (EDAP). HealthCor Catalio Acquisition vs. Check-Cap GE HealthCare Technologies Hologic Butterfly Network Nano-X Imaging LENSAR Karyopharm Therapeutics Vicarious Surgical Quince Therapeutics Edap Tms HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, community ranking, earnings, valuation and analyst recommendations. Does the media refer more to HCAQ or CHEK? In the previous week, Check-Cap had 1 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. HealthCor Catalio Acquisition's average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score. Company Overall Sentiment HealthCor Catalio Acquisition Neutral Check-Cap Neutral Which has stronger earnings & valuation, HCAQ or CHEK? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthCor Catalio AcquisitionN/AN/AN/AN/AN/ACheck-CapN/AN/A-$17.57M-$3.00-0.20 Do insiders & institutionals believe in HCAQ or CHEK? 84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer HCAQ or CHEK? Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformHealthCor Catalio AcquisitionN/AN/ACheck-CapOutperform Votes37062.71% Underperform Votes22037.29% Is HCAQ or CHEK more profitable? Company Net Margins Return on Equity Return on Assets HealthCor Catalio AcquisitionN/A N/A N/A Check-Cap N/A N/A N/A SummaryCheck-Cap beats HealthCor Catalio Acquisition on 3 of the 4 factors compared between the two stocks. Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.87M$12.83B$5.14B$9.08BDividend YieldN/A1.86%5.09%4.23%P/E RatioN/A21.6090.1317.19Price / SalesN/A10.481,116.25117.05Price / CashN/A12.7743.1037.85Price / BookN/A2.504.784.78Net IncomeN/A$273.70M$120.31M$225.60M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$0.89-4.8%N/A-15.7%$18.87MN/A0.002CHEKCheck-Cap0.344 of 5 stars$0.62-1.9%N/A-71.4%$3.60MN/A-0.2180Analyst ForecastNews CoverageGap DownGEHCGE HealthCare Technologies3.7485 of 5 stars$80.29-1.0%$95.46+18.9%+2.2%$36.68B$19.56B22.3851,000HOLXHologic4.6626 of 5 stars$72.44-1.6%$89.50+23.6%+0.8%$16.44B$4.03B22.147,063Analyst ForecastBFLYButterfly Network0.6674 of 5 stars$3.60+6.2%$3.00-16.7%+201.5%$767.02M$76.22M-8.00460Gap DownNNOXNano-X Imaging2.355 of 5 stars$7.36+6.8%$12.00+63.0%-2.0%$425.25M$10.68M-8.79190Positive NewsLNSRLENSAR0.5735 of 5 stars$7.34-2.8%$8.00+9.0%+174.0%$85.25M$48.87M-5.17110News CoverageHigh Trading VolumeKPTIKaryopharm Therapeutics3.8015 of 5 stars$0.67-4.3%$5.00+646.3%-16.5%$84.55M$148.44M-0.61380RBOTVicarious Surgical1.2841 of 5 stars$14.24+0.3%$10.25-28.0%+3.5%$84.13MN/A-1.383Positive NewsQNCXQuince Therapeutics2.903 of 5 stars$1.91-5.9%$8.50+345.0%+63.3%$84.04MN/A-1.6460Analyst ForecastAnalyst RevisionNews CoverageEDAPEdap Tms3.427 of 5 stars$2.23+1.4%$19.00+752.0%-57.0%$82.74M$63.41M-3.43307 Related Companies and Tools Related Companies CHEK Competitors GEHC Competitors HOLX Competitors BFLY Competitors NNOX Competitors LNSR Competitors KPTI Competitors RBOT Competitors QNCX Competitors EDAP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCAQ) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
